logo

Stock Screener

Forex Screener

Crypto Screener

CYRX

Cryoport, Inc. (CYRX)

$

6.96

-0.04 (-0.57%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

-0.5199

Market cap

Market cap

292.8 Million

Price to sales ratio

Price to sales ratio

1.3629

Debt to equity

Debt to equity

0.6085

Current ratio

Current ratio

5.5555

Income quality

Income quality

0.1362

Average inventory

Average inventory

22.9 Million

ROE

ROE

-0.2713



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. In the fiscal year 2023 the total costs and expenses for the company are $277,732,000.00 reflecting its overall spending and operational overhead. The company reported selling, general, and administrative expenses of $148,978,000.00 indicating its operational overhead costs. The operating income ratio is -0.57 which highlights the company's operational profitability margin. Furthermore, the income before tax ratio stands at -0.50 reflecting the pre-tax margin associated with its activities. The company's logistics offerings include the Cryoportal, a cloud-based logistics management platform for shipment management, encompassing order entry, document preparation, customs documentation, courier management, and real-time shipment tracking. Additionally, CryoPort Express Shippers are utilized to maintain the stability of biologic commodities during shipping. The company also provides informative dashboards and validation documentation through the data collected by the SmartPak Condition Monitoring System, alongside vacuum-insulated aluminum dewars and cryogenic freezer systems. Beyond shipping logistics, it offers biological specimen cryopreservation storage, sample archiving, monitoring, and tracking, as well as managing the transportation and logistics of frozen biological specimens. With a market capitalization of $348,954,912.00 the company is classified as a small-cap player. It is a key player in the Integrated Freight & Logistics industry, contributing significantly to the overall market landscape. The stock is affordable at $6.96 making it suitable for budget-conscious investors. However, it should be noted that the stock has a low average trading volume of 511,366.00 indicating lower market activity. Additionally, it belongs to the Industrials sector, driving innovation and growth within its field. Cryoport's range of services, including logistics management and consulting, positions it strategically to meet the needs of biopharma/pharma, animal health, and human reproductive medicine markets, thus reinforcing its importance in the global life sciences ecosystem.

What is Cryoport, Inc. (CYRX)'s current stock price?

The current stock price of Cryoport, Inc. (CYRX) is $6.78 as of 2025-06-10. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Cryoport, Inc. (CYRX) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B-, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict Cryoport, Inc. stock to fluctuate between $4.58 (low) and $11.20 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-06-10, Cryoport, Inc.'s market cap is $348,954,912, based on 50,137,200 outstanding shares.

Compared to Amazon.Com Inc, Cryoport, Inc. has a Lower Market-Cap, indicating a difference in performance.

To buy Cryoport, Inc. (CYRX) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CYRX. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Cryoport, Inc.'s last stock split was 1:12 on 2015-05-19.

Revenue: $228,385,000 | EPS: -$2.49 | Growth: 12.67%.

Visit https://www.cryoport.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $86.30 (2021-11-08) | All-time low: $4.58 (2025-03-04).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CYRX

zacks.com

Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?

The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

CYRX

prnewswire.com

Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025

NASHVILLE, Tenn. , April 24, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global provider of supply chain solutions for the life sciences sector, today announced that the Company will report financial results for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 after U.S. markets close.

CYRX

seekingalpha.com

Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript)

Cryoport, Inc. (NASDAQ:CYRX ) Strategic Agreement and Transaction with DHL Group Call March 31, 2025 8:30 AM ET Company Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Tom Heinzen - Vice President, Corporate Development & Investor Relations Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Conference Call Participants Puneet Souda - Leerink Partners Subbu Nambi - Guggenheim Paul Knight - KeyBanc Tejas Savant - Morgan Stanley David Larsen - BTIG David Saxon - Needham Operator Good morning, and welcome to Cryoport's Investor Conference Call. All participants will start in a listen-only mode.

CYRX

prnewswire.com

DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in specialty pharma logistics and supports Group's 2030 strategy to become a leader in life science and healthcare logistics.

CYRX

prnewswire.com

Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories

NASHVILLE, Tenn. , March 12, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' ("MVE") High-Efficiency 800 C, the latest addition to its next-generation High-Efficiency ("HE") Series of cryogenic freezers.

CYRX

seekingalpha.com

Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript

Start Time: 17:00 January 1, 0000 5:41 PM ET Cryoport, Inc. (NASDAQ:CYRX ) Q4 2024 Earnings Conference Call March 04, 2025, 17:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Anna Snopkowski - KeyBanc Capital Markets Puneet Souda - Leerink Partners David Saxon - Needham Subbu Nambi - Guggenheim David Larson - BTIG Richard Baldry - Roth Capital Kyle Crews - UBS Matt Stanton - Jefferies Operator Good afternoon, and welcome to Cryoport's Fourth Quarter and Full Year 2024 Earnings Conference Call. All participants will start in a listen-only mode.

CYRX

zacks.com

CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.51 per share a year ago.

CYRX

prnewswire.com

Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

NASHVILLE, Tenn. , Feb. 18, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2024 on Tuesday, March 4, 2025 after U.S. markets close.

CYRX

zacks.com

New Strong Buy Stocks for January 29th

MC, LFST, EAT, CYRX and HCP have been added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024.

CYRX

prnewswire.com

Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies

New High-Volume Shipping System, Improving Patient Accessibility, Will Be Showcased by Cryoport Systems at Phacilitate's Advanced Therapies Week in Dallas NASHVILLE, Tenn. , Jan. 21, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today unveiled its Cryoport Express® Cryogenic HV3 Shipping System ("HV3"), the Company's newest product innovation in Cryoport's comprehensive portfolio of global end-to-end temperature-controlled supply chain offerings.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener